T · 7702.T
JMS Co.,Ltd.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Hiroshima 730-8652
- Website
- jms.cc
Price · as of 2025-03-31
$427.00
Market cap 10.82B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $983.97 | +130.44% |
| Intrinsic Value(DCF) | $167.63 | -60.74% |
| Graham-Dodd Method(GD) | $1,418.38 | +232.17% |
| Graham Formula(GF) | $53.17 | -87.55% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $353.01 | $580.33 | $0.00 | $1,217.99 | $543.56 |
| 2012 | $333.42 | $532.61 | $0.00 | $1,143.59 | $471.83 |
| 2013 | $455.88 | $865.41 | $0.00 | $1,409.02 | $748.03 |
| 2014 | $424.02 | $752.27 | $0.00 | $1,054.46 | $148.60 |
| 2015 | $457.95 | $741.30 | $0.00 | $1,077.24 | $61.62 |
| 2016 | $421.29 | $884.34 | $0.00 | $1,177.86 | $369.86 |
| 2017 | $508.80 | $907.35 | $0.00 | $1,213.19 | $227.32 |
| 2018 | $530.35 | $941.62 | $0.00 | $1,178.90 | $255.12 |
| 2019 | $552.28 | $946.95 | $0.00 | $1,299.93 | $514.41 |
| 2020 | $687.19 | $1,073.95 | $0.00 | $1,491.75 | $721.30 |
| 2021 | $724.12 | $1,046.84 | $0.00 | $1,520.64 | $469.42 |
| 2022 | $498.49 | $927.40 | $0.00 | $1,422.31 | $307.26 |
| 2023 | $523.89 | $969.01 | $0.00 | $1,374.24 | $199.03 |
| 2024 | $505.45 | $875.28 | $0.00 | $1,383.42 | $0.00 |
| 2025 | $419.08 | $983.97 | $0.00 | $1,418.38 | $53.17 |
AI valuation
Our deep-learning model estimates JMS Co.,Ltd.'s (7702.T) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $983.97
- Current price
- $427.00
- AI upside
- +130.44%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$167.63
-60.74% upside
Graham-Dodd
$1,418.38
+232.17% upside
Graham Formula
$53.17
-87.55% upside
About JMS Co.,Ltd.
JMS Co.,Ltd. manufactures, sells, exports, and imports medical devices and pharmaceuticals in Japan and internationally. The company offers infusion and transfusion sets, infusion sets with a needleless access port, disposable needles and syringes, safety scalp vein sets, safety venous indwelling catheters, extension tubes, oral/enteral nutrition systems, infusion and syringe pumps, semisolid nutrition feeding devices, blood bags, blood collection scale and mixers, high-frequency tube sealers, and serum collection sets for infusion and transfusion therapy. It also provides general medical supplies, including latex surgeon's gloves and examination gloves, plastic gloves, treatment sheets, surgical gowns, masks and caps, drainage bags, and surgical tapes used in medical institutions. In addition, the company offers central dialysate delivery systems, hemodialysis machines, AV fistula needles, accidental needlestick prevention systems, hemodialysis blood tubing sets, dialyzers, prefilled syringes, hemodialysis kits, single patient dialysis machines, dialysis solution for CAPD, and automatic peritoneal dialysis machines for hemodialysis and peritoneal dialysis. Further, it provides cardiovascular therapy products, such as cardiopulmonary equipment, membrane oxygenators, heat exchangers, pacemakers, microcatheters, and cardiopulmonary blood tubing sets. JMS Co.,Ltd. was incorporated in 1947 and is headquartered in Hiroshima, Japan.
- CEO
- Ryuji Katsura
- Employees
- 5.28K
- Beta
- 0.24
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($167.63 ÷ $427.00) − 1 = -60.74% (DCF, example).